Leuconostoc bacteremia in a patient with amyloidosis secondary to rheumatoid arthritis and tuberculosis arthritis

ShinJ.H.; HerM.; MoonC.; KimD.; LeeS.H.; JungS.J.

首页> 外文期刊>Modern rheumatology >Leuconostoc bacteremia in a patient with amyloidosis secondary to rheumatoid arthritis and tuberculosis arthritis

【24h】

Leuconostoc bacteremia in a patient with amyloidosis secondary to rheumatoid arthritis and tuberculosis arthritis

机译：类风湿性关节炎和结核性关节炎继发性淀粉样变性病患者中的白带阳性菌血症

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Leuconostoc infections are rare and usually occur in immunocompromised patients. This report describes a case of Leuconostoc lactis bacteremia in a patient with coexisting rheumatoid arthritis and tuberculosis arthritis. A disrupted gastrointestinal barrier due to gastrointestinal amyloidosis in long-standing rheumatoid arthritis and tuberculosis arthritis could be a risk factor for Leuconostoc bacteremia. Despite aggressive antibiotic treatment, the patient progressed to septic shock and multiorgan failure. The fatal course might have been caused by rapid progression of gastrointestinal pathology, which could be a risk factor for Leuconostoc bacteremia.

机译：Leuconostoc感染很少见，通常发生在免疫功能低下的患者中。该报告描述了风湿性关节炎和结核性关节炎并存的患者中乳酸乳球菌菌血症的病例。在长期存在的类风湿性关节炎和结核性关节炎中，由于胃肠道淀粉样变性引起的胃肠道屏障破坏可能是亮粘膜菌血症的危险因素。尽管进行了积极的抗生素治疗，该患者仍发展为败血性休克和多器官功能衰竭。致命的病程可能是由胃肠道病理的快速发展引起的，这可能是亮粘膜菌血症的危险因素。

著录项

来源
《Modern rheumatology》 |2011年第6期|共5页
作者
ShinJ.H.; HerM.; MoonC.; KimD.; LeeS.H.; JungS.J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
Amyloidosis; Leuconostoc lactis; Rheumatoid arthritis; Tuberculosis;

机译：淀粉样变性;乳酸乳球菌;类风湿关节炎;结核病;

相似文献

外文文献
中文文献
专利

1. Leuconostoc bacteremia in a patient with amyloidosis secondary to rheumatoid arthritis and tuberculosis arthritis [J] . ShinJ.H., HerM., MoonC., Modern rheumatology . 2011,第6期

机译：类风湿性关节炎和结核性关节炎继发性淀粉样变性病患者中的白带阳性菌血症
2. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients [J] . Pamuk Omer Nuri, Kalyoncu Umut, Aksu Kenan, Rheumatology international. . 2016,第7期

机译：多中心生物制剂治疗土耳其类风湿性关节炎和强直性脊柱炎患者继发性淀粉样变性的报告
3. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis [J] . NakamuraT., KumonY., HirataS., Clinical and experimental rheumatology . 2014,第4期

机译：Abatacept在类风湿关节炎继发的A淀粉样变性病中可能是有效和安全的
4. COMPARISON OF CLINICAL AND IMMUNOHISTOCHEMICAL FINDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SECONDARY AMYLOIDOSIS [C] . D. Povilenaite, V. Graziene, I. Butrimiene, International Symposium on Amyloidosis . 2005

机译：类风湿性关节炎患者临床和免疫组织化学发现与次生淀粉样蛋白症的比较
5. The novel use of recombinant granulocyte-macrophage colony stimulating factor (GM-CSF) to reverse cerebral amyloidosis and cognitive impairment in Alzheimer's disease mouse models: Insights from the investigation of Rheumatoid arthritis as a negative risk factor for Alzheimer's disease [D] . Boyd, Timothy David 2010

机译：重组粒细胞巨噬细胞集落刺激因子（GM-CSF）在阿尔茨海默氏病小鼠模型中逆转脑淀粉样变性和认知障碍的新用途：类风湿关节炎作为阿尔茨海默氏病的阴性危险因素研究的启示
6. Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis [O] . Masato Sawamura, Naoki Sawa, Hideomi Fujiwara, 2020

机译：Abatacept改善了患有类风湿性关节炎的患者患者的AA淀粉样变性的顽固蛋白质失肠病
7. Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis [O] . Masato Sawamura, Naoki Sawa, Hideomi Fujiwara, 2020

机译：Abatacept改善了患有类风湿性关节炎的患者患者的AA淀粉样变性的顽固蛋白质失肠病

Leuconostoc bacteremia in a patient with amyloidosis secondary to rheumatoid arthritis and tuberculosis arthritis

摘要

著录项

相似文献

相关主题

期刊订阅